Ingevity Corporation (NYSE:NGVT) Stock Has Average Price Target of $80.00 According to Brokerages

Ingevity Corporation (NYSE:NGVT) has been assigned a consensus rating of “Hold” from the five brokerages that are currently covering the stock, Marketbeat.com reports. Three research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $80.00.

Several research firms recently commented on NGVT. Weiss Ratings upgraded shares of Ingevity from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, October 8th. Wall Street Zen cut shares of Ingevity from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 1st.

Ingevity Trading Up 1.7%

NYSE NGVT opened at $70.27 on Friday. The company has a quick ratio of 1.15, a current ratio of 1.61 and a debt-to-equity ratio of 22.52. Ingevity has a twelve month low of $45.85 and a twelve month high of $79.29. The company has a market cap of $2.42 billion, a price-to-earnings ratio of 14.45 and a beta of 1.14. The business’s fifty day moving average is $71.35 and its 200 day moving average is $71.89.

Ingevity (NYSE:NGVT) last issued its quarterly earnings data on Wednesday, July 29th. The company reported $1.74 earnings per share for the quarter, topping analysts’ consensus estimates of $1.33 by $0.41. Ingevity had a return on equity of 284.70% and a net margin of 4.65%. The business had revenue of $314.10 million for the quarter, compared to analyst estimates of $312.20 million. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. As a group, sell-side analysts expect that Ingevity will post 5.40 EPS for the current fiscal year.

Insider Buying and Selling at Ingevity

In related news, SVP Ryan Fisher sold 2,709 shares of the stock in a transaction on Monday, August 3rd. The stock was sold at an average price of $73.72, for a total value of $199,707.48. Following the completion of the sale, the senior vice president directly owned 15,722 shares in the company, valued at $1,159,025.84. This represents a 14.70% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO David Li sold 5,000 shares of the stock in a transaction on Monday, August 17th. The shares were sold at an average price of $75.83, for a total value of $379,150.00. Following the completion of the sale, the chief executive officer owned 120,636 shares of the company’s stock, valued at $9,147,827.88. The trade was a 3.98% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 17,801 shares of company stock worth $1,347,481. 0.88% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Ingevity

Institutional investors have recently made changes to their positions in the stock. Contravisory Investment Management Inc. raised its position in shares of Ingevity by 16.5% during the third quarter. Contravisory Investment Management Inc. now owns 4,556 shares of the company’s stock worth $322,000 after acquiring an additional 644 shares during the last quarter. Sax Wealth Advisors LLC acquired a new position in shares of Ingevity in the third quarter worth approximately $490,000. Farther Finance Advisors LLC lifted its stake in shares of Ingevity by 3,106.8% in the third quarter. Farther Finance Advisors LLC now owns 4,265 shares of the company’s stock worth $302,000 after acquiring an additional 4,132 shares during the period. Cim Investment Management Inc. bought a new stake in Ingevity in the second quarter valued at approximately $203,000. Finally, Squarepoint Ops LLC boosted its holdings in Ingevity by 60.4% in the second quarter. Squarepoint Ops LLC now owns 14,776 shares of the company’s stock valued at $1,103,000 after acquiring an additional 5,562 shares during the last quarter. Institutional investors own 91.59% of the company’s stock.

Ingevity Company Profile

Ingevity Corporation (NYSE: NGVT) is a specialty chemicals and materials company headquartered in North Charleston, South Carolina. The company develops products designed to improve environmental performance, enhance infrastructure and support industrial manufacturing.

Ingevity’s products include activated carbon technologies used in automotive evaporative-emissions control systems, as well as applications involving air and water purification. The company also produces specialty chemicals and materials used in pavement preservation, asphalt modification and other industrial applications.